comparemela.com

Latest Breaking News On - ப்ராடக்ட்ஸ் நிறுவனம் - Page 12 : comparemela.com

WHO gives emergency approval to Sinopharm, first Chinese Covid vaccine

GENEVA: The World Health Organisation approved a Covid-19 vaccine from China’s state-owned drugmaker Sinopharm for emergency use on Friday, a boost to Beijing’s push for a big role in inoculating the world. The vaccine, one of two main Chinese coronavirus vaccines that collectively have already been given to hundreds of millions of people in China and elsewhere, is the first developed by a non-Western country to win WHO backing. It is also the first time the WHO has given emergency use approval to a Chinese vaccine for any infectious disease. A WHO emergency listing is a signal to national regulators that a product is safe and effective. It also allows it to be included in COVAX, a global programme to provide vaccines mainly for poor countries, which has hit supply problems.

WHO approves China s Sinopharm vaccine - Newspaper

GENEVA: The World Health Organisation approved a Covid-19 vaccine from China’s state-owned drugmaker Sinopharm for emergency use on Friday, a boost to Beijing’s push for a big role in inoculating the world. The vaccine, one of two main Chinese coronavirus vaccines that collectively have already been given to hundreds of millions of people in China and elsewhere, is the first developed by a non-Western country to win WHO backing. It is also the first time the WHO has given emergency use approval to a Chinese vaccine for any infectious disease. A WHO emergency listing is a signal to national regulators that a product is safe and effective. It also allows it to be included in COVAX, a global programme to provide vaccines mainly for poor countries, which has hit supply problems.

WHO emergency approval for COVID vaccine made by Chinese company

The World Health Organisation (WHO) has granted emergency approval for the coronavirus (COVID-19) vaccine made by Chinese company Sinopharm. It is the first vaccine developed by a non-Western country to get WHO backing. The vaccine has already been given to millions of people in China and elsewhere. The WHO had previously only approved the vaccines made by Pfizer, AstraZeneca, Johnson & Johnson and Moderna. But individual health regulators in various …

WHO approves China s Sinopharm vaccine in potential boost to COVAX pipeline

WHO approves China s Sinopharm vaccine in potential boost to COVAX pipeline Today 12:00 pm JST Today | 12:23 pm JST GENEVA The World Health Organization(WHO) approved for emergency use a COVID-19 vaccine from China s state-owned drugmaker Sinopharm on Friday, bolstering Beijing s push for a bigger role in inoculating the world. The vaccine, one of two main Chinese coronavirus vaccines that have been given to hundreds of millions of people in China and elsewhere, is the first developed by a non-Western country to win WHO backing. It is also the first time the WHO has given emergency use approval to a Chinese vaccine for any infectious disease. Earlier this week, separate WHO experts had expressed concern about the quality of data the company provided on side effects.

WHO approves Sinopharm vaccine in potential boost to COVAX

Recommends Sinopharm for all ages above 18, in two doses Says Sinopharm has estimated 79% overall efficacy rate (Adds Sinopharm statement in paragraph 8, updates vaccine numbers in final paragraph) By Stephanie Nebehay GENEVA, May 7 (Reuters) - The World Health Organization (WHO) approved for emergency use a COVID-19 vaccine from China s state-owned drugmaker Sinopharm on Friday, bolstering Beijing s push for a bigger role in inoculating the world. The vaccine, one of two main Chinese coronavirus vaccines that have been given to hundreds of millions of people in China and elsewhere, is the first developed by a non-Western country to win WHO backing. It is also the first time the WHO has given emergency use approval to a Chinese vaccine for any infectious disease. Earlier this week, separate WHO experts had expressed concern about the quality of data the company provided on side effects.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.